Stanford Advisors


All Publications


  • A multi-omics map of diabetic nephropathy reveals c-Jun as a driver of tubular injury and metabolic stress. bioRxiv : the preprint server for biology Deng, Q., Liu, Y., Bracey, N. A., Wang, Y. C., Wadsworth, P. A., Afrin, M., Santoro, M., Chen, S. Y., Wu, J. C., Charu, V., Wernig, G. 2026

    Abstract

    Diabetic nephropathy (DN) is a major cause of end-stage renal disease, yet the molecular mechanisms driving tubular injury and fibrosis remain poorly defined. Here, we integrated single-cell multiplexed protein imaging, spatial transcriptomics, single-nucleus and single-cell RNA sequencing and chromatin accessibility profiling to comprehensively characterize human DN pathology. Our multi-modal analysis precisely maps kidney cell types and their spatial distributions, immune-fibrotic interactions, and key transcriptional regulators. We identified eight distinct cellular neighborhoods defining the immune-fibrotic microenvironment and uncovered molecular networks driving tubular injury and fibrosis. JUN (encoding c-Jun) emerged as a central regulator of transcriptional reprogramming during tubular injury and fibrogenic remodeling. In a diabetic mouse model, c-Jun is activated in injured proximal tubules. Using an inducible c-Jun mouse model, we demonstrated that tubular-specific c-Jun activation alone is sufficient to induce tubular injury, chronic inflammation, progressive fibrosis, and systemic metabolic alterations, including impaired glucose homeostasis. We also observed reduced expression of SLC4A4, a bicarbonate transporter essential for proximal tubular function, in injured tubules. Together, our findings establish a spatially resolved framework for understanding DN pathogenesis and identify c-Jun as a key mediator of tubular injury and fibrosis in diabetic kidney disease.

    View details for DOI 10.64898/2026.06.09.731164

    View details for PubMedID 42327115

    View details for PubMedCentralID PMC13278112

  • <i>Trypanosoma brucei</i> TEL2 inhibits VSG switching and protects PIKKs from the 26S proteasome-mediated degradation MICROBIOLOGY SPECTRUM Sayeed, S., Kushwaha, P. P., Afrin, M., Li, B. 2026: e0351625

    Abstract

    Trypanosoma brucei causes debilitating human African trypanosomiasis. It undergoes antigenic variation and sequentially expresses distinct VSGs, its major surface antigen, thereby effectively evading the host's immune response. We have shown that many telomere proteins suppress VSG switching, as VSGs are expressed exclusively from subtelomeric loci. We have now identified the T. brucei TEL2 homolog based on its sequence and predicted structure similarities to those of known TEL2 homologs. TEL2 homologs have a conserved function of maintaining the protein stability of PI3K-related protein kinases (PIKKs). Interestingly, TbTEL2 maintains the stability of TbATR and most other PIKK proteins by protecting them from the 26S proteasome-mediated degradation. This is different from mechanisms revealed in mammals and fission yeast, where TEL2 homologs act as an HSP90 co-chaperone and ensure co-translational maturation of PIKKs. In addition, TbTEL2 is essential for genome integrity and acts as another critical player in antigenic variation regulation. More DNA breaks have been detected at multiple T. brucei loci, including both active and silent subtelomeric VSG expression sites in TbTEL2-depleted cells. Furthermore, a transient depletion of TbTEL2 leads to a significant increase in the number of VSG switching events via DNA recombination-mediated and transcriptional switching pathways. Hence, the increased genome instability promotes antigenic variation potential. However, only a trace amount of γH2A, a marker of DNA damage, was detected transiently upon TbTEL2 depletion, presumably due to the diminution of H2A kinases in these cells, suggesting that persistent ATM/ATR-mediated damage signaling is not essential for the increase in VSG switching rate.IMPORTANCETrypanosoma brucei causes sleeping sickness in humans and nagana in cattle, causing a severe economic burden in sub-Sahara Africa. Antigenic variation is a key pathogenesis mechanism that enables long-term parasitic infections and renders vaccination ineffective. We have identified T. brucei TEL2 and shown that it is indispensable for parasite proliferation, essential for genome integrity, and critical for the regulation of antigenic variation. Importantly, TbTEL2 maintains the stability of PIKK proteins that are key players in various important cellular processes, indicating that TbTEL2 is a central regulator essential for parasite survival in its mammalian host. Importantly, we found that TbTEL2 protects PIKKs from the 26S proteasome-mediated protein degradation. This is distinct from the scenarios in mammals and fission yeast, where TEL2 homologs act as an HSP90 co-chaperone and ensure co-translational maturation of PIKKs. Characterizing the parasite's essential processes with unique mechanisms will help eventual eradication of T. brucei infections.

    View details for DOI 10.1128/spectrum.03516-25

    View details for Web of Science ID 001778431100001

    View details for PubMedID 42214372

  • Spatial Characterization of Molecular Pathways Suggests the Dysregulation of LGR5 Expressing Fibroblasts in Patients with sclerodermatous Chronic Graft-Vs-Host Disease Afrin, M., Nasr, S., De Souza, C., Howitt, B., Mueller, A., Arai, S., Shizuru, J., Wernig, G. ELSEVIER. 2024
  • The RRM-mediated RNA binding activity in T. brucei RAP1 is essential for VSG monoallelic expression. Nature communications Gaurav, A. K., Afrin, M., Yang, X., Saha, A., Sayeed, S. K., Pan, X., Ji, Z., Wong, K. B., Zhang, M., Zhao, Y., Li, B. 2023; 14 (1): 1576

    Abstract

    Trypanosoma brucei is a protozoan parasite that causes human African trypanosomiasis. Its major surface antigen VSG is expressed from subtelomeric loci in a strictly monoallelic manner. We previously showed that the telomere protein TbRAP1 binds dsDNA through its 737RKRRR741 patch to silence VSGs globally. How TbRAP1 permits expression of the single active VSG is unknown. Through NMR structural analysis, we unexpectedly identify an RNA Recognition Motif (RRM) in TbRAP1, which is unprecedented for RAP1 homologs. Assisted by the 737RKRRR741 patch, TbRAP1 RRM recognizes consensus sequences of VSG 3'UTRs in vitro and binds the active VSG RNA in vivo. Mutating conserved RRM residues abolishes the RNA binding activity, significantly decreases the active VSG RNA level, and derepresses silent VSGs. The competition between TbRAP1's RNA and dsDNA binding activities suggests a VSG monoallelic expression mechanism in which the active VSG's abundant RNA antagonizes TbRAP1's silencing effect, thereby sustaining its full-level expression.

    View details for DOI 10.1038/s41467-023-37307-0

    View details for PubMedID 36949076

    View details for PubMedCentralID PMC10033678